Extendicare (EXE) Earnings Date, Estimates & Call Transcripts C$7.71 +0.07 (+0.92%) (As of 07/26/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlines Earnings SummaryUpcoming Earnings DateAug. 12After Market ClosesConfirmedActual EPS (May. 15) C$0.14 Beat By C$0.14 Get Extendicare Earnings AlertsEnter your email address below to receive the latest news and earnings results for EXE and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueEXE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.EXE Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad American Hartford Gold GroupDave Ramsey Makes Big Mistake Live On AirDave Ramsey Is Dangerously Wrong And Here’s Why>> Asked whether we’re on the cusp of a US Dollar crash, Dave Ramsey made a stunning miscalculation while live on air: “Am I worried about this? Absolutely not.” Frankly, I've never seen someone so confident in being wrong… Because what’s happening to the US Dollar is not something you should “keep an eye on”… But instead, is an imminent threat you should get ahead of right NOW.GET THE FREE GUIDE Extendicare Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:C$0.47 EPSEXE Earnings Date and InformationExtendicare last announced its earnings data on May 15th, 2024. The reported C$0.14 EPS for the quarter. The company had revenue of C$367.10 million for the quarter, compared to analysts' expectations of C$310 million. Extendicare has generated C$0.41 earnings per share over the last year (C$0.41 diluted earnings per share) and currently has a price-to-earnings ratio of 18.8. Extendicare has confirmed that its next quarterly earnings report will be published on Monday, August 12th, 2024. Read More Extendicare Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/12/2024(Confirmed)------- 5/15/2024Q1 2024-C$0.14+C$0.14C$0.14C$310.00 millionC$367.10 million3/7/2024Q4 2023-C$0.10+C$0.10C$0.10-C$350.18 million11/9/2023Q3 2023-C$0.14+C$0.14C$0.14-C$322.53 million8/10/2023Q2 2023C$0.08C$0.02C($0.06)C$0.02-C$307.54 million5/4/2023Q1 2023C$0.06C$0.14+C$0.08C$0.14C$299.70 millionC$324.71 million3/2/2023Q4 2022C$0.05C($0.08)C($0.13)C($0.14)C$309.50 millionC$310.39 million Get the Latest News and Ratings for EXE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. 11/10/2022Q3 2022C$0.03C$0.04+C$0.01C$0.04C$312.80 millionC$308.89 million8/9/2022Q2 2022C$0.05C$0.04C($0.01)C($0.64)C$308.10 millionC$296.59 million5/12/2022Q1 2022C$0.11C$0.04C($0.07)C$0.04C$314.50 millionC$305.71 million2/24/2022Q4 2021-C($0.05)C($0.05)C($0.06)-C$319.37 million11/4/2021Q3 2021C$0.11C$0.03C($0.08)C($0.01)C$305.80 millionC$310.13 million8/5/2021Q2 2021C$0.06C$0.01C($0.05)C$0.01C$307.40 millionC$307.45 million5/12/2021Q1 2021C$0.15C$0.09C($0.06)C$0.09C$306.90 millionC$322.38 million2/25/2021Q4 2020-C$0.17+C$0.17C$0.15-C$307.74 million11/12/2020Q3 2020C$0.16C$0.36+C$0.20C$0.36C$273.40 millionC$296.79 million8/13/2020Q2 2020C$0.09C($0.08)C($0.17)C($0.12)C$257.30 millionC$281.95 million5/14/2020Q1 2020C$0.10C$0.02C($0.08)C($0.02)C$260.40 millionC$271.82 million2/27/2020Q4 2019C$0.14C$0.05C($0.09)C($0.01)C$282.50 millionC$290.90 million11/7/2019Q3 2019C$0.17C$0.06C($0.11)C$0.04C$279.50 millionC$282.73 million8/14/2019Q2 2019C$0.16C$0.07C($0.09)C$0.04C$280.60 millionC$284.05 million Extendicare Earnings - Frequently Asked Questions When is Extendicare's earnings date? Extendicare has confirmed that its next quarterly earnings data will be published on Monday, August 12th, 2024. Learn more on EXE's earnings history. How much revenue does Extendicare generate each year? Extendicare (TSE:EXE) has a recorded annual revenue of C$1.35 billion. How much profit does Extendicare generate each year? Extendicare (TSE:EXE) has a recorded net income of C$35.50 million. EXE has generated C$0.41 earnings per share over the last four quarters. What is Extendicare's price-to-earnings ratio? Extendicare (TSE:EXE) has a trailing price-to-earnings ratio of 18.80 and a forward price-to-earnings ratio of 16.45. More Earnings Resources from MarketBeat Related Companies: SIA Earnings Results DR Earnings Results NLH Earnings Results PHA Earnings Results GUD Earnings Results ACB Earnings Results VMD Earnings Results KSI Earnings Results VHI Earnings Results OPS Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Leading Healthcare Provider Stock Soars on Earnings BeatViking Therapeutics: Pharma Stock Soars on Positive EarningsEarnings Season Sell-Off: Is This Tech Giant a Buy?Pharma Leader Beats on Earnings, But Shares FallSemiconductor Giant Posts Big Earnings Beat, but Shares Stay FlatIs This Industrial Stock a Buy After Recent Earnings Boost?Consumer Staple Stock's Q2 Earnings: Key Surprises and Challenges This page (TSE:EXE) was last updated on 7/26/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredMust-See: Elon’s New Invention is Absolutely InsaneCould Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | SponsoredElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored5 Stocks that could triple in a week Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
